| Literature DB >> 33425254 |
Beatriz García-Jiménez1,2, Jesús Torres-Bacete1, Juan Nogales1,3.
Abstract
Microbes do not live in isolation but in microbial communities. The relevance of microbial communities is increasing due to growing awareness of their influence on a huge number of environmental, health and industrial processes. Hence, being able to control and engineer the output of both natural and synthetic communities would be of great interest. However, most of the available methods and biotechnological applications involving microorganisms, both in vivo and in silico, have been developed in the context of isolated microbes. In vivo microbial consortia development is extremely difficult and costly because it implies replicating suitable environments in the wet-lab. Computational approaches are thus a good, cost-effective alternative to study microbial communities, mainly via descriptive modelling, but also via engineering modelling. In this review we provide a detailed compilation of examples of engineered microbial communities and a comprehensive, historical revision of available computational metabolic modelling methods to better understand, and rationally engineer wild and synthetic microbial communities.Entities:
Keywords: Computational methods; Design; Engineering; Genome-scale metabolic modelling; Microbial community; Optimization; Synthetic microbial consortia
Year: 2020 PMID: 33425254 PMCID: PMC7773532 DOI: 10.1016/j.csbj.2020.12.003
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Fig. 1A, Schematic representation of the basic ecological interactions between the microbial strains in co-culture, green positive and red negative interactions. B, Schematic representation of the SMCs categories. Black arrows stability interactions and green arrows functionality interactions. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Recent examples of engineering Synthetic Microbial consortia.
| Microorganism | Interaction | Goal to optimize | C-source | Yield | Ref. |
|---|---|---|---|---|---|
| Unidirectional Non-Distributed | |||||
Sucrose production in presence of 2,4-DNT 2,4-DNT cleaning PHA production | CO2 | 1.2 g/L sucrose at 120h. 250 mM 2,4-DNT cleaning at 24 h. 5.1 mg/L day PHA | |||
3-HP production Sucrose production | CO2 | Up to 68.29 mg/L 3-HP at 7 days 600 mg/L sucrose at 144 h | |||
Lactate production Flavin production (S. oneidensis) Inoculum ratio Electric power | Glycerol | 2.1-times increase lactate production 7.9-time increase flavin production Inoculum ratio 1:10 19.9 mW/m2 power density | |||
Biomass PHA production P(3HB-co-3HV) production | Sucrose | Biomass 3.79 g dcw/L PHA 63% w/w P(3HB-co-3HV) 66% w/w | |||
Acetate production | CO | 0.157 mM acetate from 0.439 mM CO | |||
Organic acids production | Corn stove | 6.87 g/L fumaric acid 4.4 g/L lactic acid | |||
Butanol production | Rice straw | 6.5 g/L butanol from 40 g/L rice straw | |||
Acetate removal | Glucose | Increase of Acetate reduction from 13 mM to 3mM | |||
Isobutanol production | Cellulose | 1.88 g/L from 20g/L cellulose | |||
Xylane hydrolysis Ethanol production | Xylan | 38.6% hydrolysis 3.71 g/L ethanol | |||
Carotenoids production | Corn syrup | 8.2 mg/L carotenoids | |||
| Multidirectional Non-Distributed | |||||
Production of Lys and cadaverine or L-PA | Starch | 12.3 mM Lys 6.8 mM cadaverine or 3.4 mM L-PA | |||
α-amylase production Co-culture conditions | Starch | 1.8-times increase α-amylase production Bacterial;yeast ratio of 1:125; Tª of 33.5°C and pH of 5.5 | |||
| In co-culture | Chalcomycin A | Maltose | n.d. | ||
PHA and PHB | octanoate | 80 % recovery in the extracellular medium | |||
| In co-culture at limited iron | population fitness | Casamino acids | Increase in the growth of B. cenoceparia | ||
Electric density | Glucose | 14-times increase of the electric density | |||
| Unidirectional Distributed | |||||
| Hydrogel compartmentalized | Stability of the compartmentalized consortium Inoculum ratio Betaxhanthins production | Glucose | Up to 10 times reutilization of the compartmentalized consortium Inoculum Optimized betaxhantin production | ||
| Three | The rosmarinic acid biosynthetic pathway was divided in three | Rosmarinic acid | Glucose | 172 mg/L rosmarinic acid | |
| The glutarate biosynthetic pathway from Lys was splitted in two | Glutarate production | Lysine | 43.8 g/L glutarate | ||
Resveratrol glucosides | Glucose | 92 mg/L resveratrol glucosides | |||
| When both strains are growing using glucose as carbon source they compete for it. When xylose is used instead of glucose, | Growth | Xylose | Changed from competitive to cooperative interaction the growth was improved in co-culture | ||
Inoculation ratio Naringenin production | Glucose | P2C:BLNA ratio 1:5 41.5 mg/L naringenin at 36 h | |||
| Four strains of | The synthetic plants pathway to produce Anthocyanins was divided and inserted in four different | Anthocyanins production | Glucose | 9 mg/L anthocyanidin-3-O-glucosides | |
| The resveratrol biosynthetic pathway is divided in two E. | Resveratrol production | Glycerol | 22.6 mg/L resveratrol in 30 hours | ||
Co-culture stability Oxygenated taxanes | Xylose | 33 mg/L oxygenated taxanes | |||
| One | Muconic acid 4-hydroxybenzoic acid | Glucose Xylose | 4.7 g/L of muconic acid 2.3 g/L of 4-hydroxybenzoic acid | ||
| Four strains of | The enzymatic pathway to produce ethanol from cellulose was divided in four | Ethanol production | Cellulose | 1.25 g/L of ethanol | |
| Multidirectional Distributed | |||||
Diesel biodegradation | Hexadecane | 85.54 % diesel removal | |||
| One | Salidroside production C-source ratio Inoculum ratio | Xylose | 6.03 g/L at 120 h fermentation Glucose:xylose ratio 4:1 Inoculum ratio tyrosol producer:salidroside producer 1:2 | ||
| One | Cadaverine production C-source ratio Inoculum ratio C:N ratio Fermentation conditions | Glucose | Up to 28.5 g/L with constant feeding at 40 h Glucose:glycerol ratio 8:1 Strains ratio 10:1 C:N ratio 3:2 others | ||
Electricity production | Glucose | 15 days production with an efficiency of 55.7% | |||
Current density | Glucose | Increase of the current density to 2.0 μA/cm2. | |||
Growth | Glucose | 3-fold growth rate increase | |||
Descriptive microbial community modelling methods classification. The ‘In-vivo consortia categories’ defines the most complex category from those defined in Fig. 1 that could be modelled with the descriptive computational approach (both unidirectional and multidirectional could be modelled in all computational categories). There are additional multiple ad-hoc algorithms or methods not listed in the ‘Tool’ column but collected in Table 3.
| In-vivo consortia categories | Properties | Tool | |
|---|---|---|---|
| Static/Unified | Uni/Multidirectional | Unique GEM Combined biomass objective function No metabolite exchanges High number of strains | MO-FBA/FVA, Kbase |
| Static/Multi-part | Uni/Multidirectional | Individual GEMs Pool of metabolites Models connected by direct exchange reactions No metabolite accumulation in the medium | OptCom, cFBA, Mminte, SteadyCom, Microbiome modeling toolbox, CarveMe, MICOM |
| Dynamic | Uni/Multidirectional | Allowing community evolution over time Metabolite concentration in the medium Low number of strains | DMMM, d-OptCom, COMETS, MCM, evoFBA, BacArena, Daphne, MMODES |
Applications descriptive microbial community modelling approaches. There are three blocks corresponding to the descriptive modelling approach category described in Table 2. The ‘tool’ column includes the name of the algorithm or method defined in that application to describe the communities, and link to the software if it is available. ‘In vivo validation’ column indicates if the application has been validated with in vivo data or they are in silico-based results.
| Modelled Species | Application | Tool | Ref. | |
|---|---|---|---|---|
| Static/unified | ||||
| Description of product formation in fermentative conditions, from glucose depending on pH and substrate concentration. | No | |||
| Large-scale studies based on integration of metabolic capabilities in a common network with multiple species, with nodes representing metabolites and edges connecting substrates to products. Phylogenetic analysis and prediction of interactions based on that metabolic network. | No | |||
| Study of metabolic variability and cohabitation categorize interactions versus growth rate. | No | |||
| The first microbial consortia modelling classification, representing the consortium with different approaches. Description of relative abundances, biomass productivity and generation of toxic by-products. | No | |||
| Study of trophic and electron accepting interactions of subsurface anaerobic environments. | Yes | |||
| Description of common metabolic network of naphthalene-degrading bacterial communities based on metaproteomic and taxonomic data. | Yes | |||
| Study the extent of resource competition and metabolic exchanges in over 800 microbial communities. | No | |||
| Study of autotrophic capabilities (identification of pathways for C and N assimilation) with a metabolic network based on metagenomics data. | No | |||
| Study of photoautotrophic cyanobacterium-heterotroph consortium. | No | KBase | ||
| Description of ecosystem of hot spring microbial mats, with different behaviour between day and night. | No | MO-FBA/FVA | ||
| Static/multi-part | ||||
| Study of mutualistic interactions between sulphate-reducing bacteria and methanogens, predicting fluxes (intracellular and exchange between species). | Yes | |||
| Studying a syntrophic interaction to increase methane production in anaerobic conditions, with an efficient consumption of by-products. | No | |||
| Defining multi-tissue models, to study diabetes in human (including gene expression data) or analysing how | No | |||
| Study of the metabolism of malaria infection, over different life cycle stages of the pathogen. | No | |||
| Estimation of medium composition to allow symbiosis between binary pairs of species. | No | |||
| Description of synthetic mutualism interactions in auxotrophic | Yes | |||
| Quantifying a syntrophic association; assessing the level of sub-optimal growth in phototrophic microbial mats depending on community composition; and evaluating the direction of inter-species metabolite and electron transfer. | No | OptCom | ||
| Analysis community parameters (relative biomass abundances, etc) at balanced growth. | No | cFBA | ||
| Study of interspecies electron transfer mechanisms in syntrophic associations, in genomic and transcriptomics. | Yes | |||
| Prediction of interactions between 3 key representative bacteria in the human gut, and analysing their individual contributions to secrete SCFA. | Yes | |||
| Predicting demand for acetate and production of butyrate, in 2 gut strains related to Chron’s disease, using OptCom tool. | No | |||
| Understanding of vitamin C production by an artificial consortium, study of subsystems and other possible metabolites to secrete. | No | |||
| Study of interactions between gut microbes and human small intestinal enterocytes, under anoxic and normoxic conditions. | No | |||
| Study of bioleaching (oxidizing iron) in a bacteria-archaea consortium presents in natural environment, with chemo-mixotrophic growth. | No | |||
| Assessment of NO redox reactions contributes to N2O formation during nitrification, in 9 different consortia with variable composition selected among 4 AOB and 4 NOB. | Yes | |||
| Exploring pairwise microbial metabolic interactions, using 16S data from microbiome studies. Evaluating a sulphate-reducing bacteria growth in gut microbiome with different diets with data from | No | MMinte | ||
| − 4 | Maximizing community stability (common growth). | No | SteadyCom | |
| Automatic reconstruction of single strain models (from 238 to 2472 reactions per model) with the possibility to merge in a community one, analysing the number of compounds that can be exchanged. | No | CarveMe | ||
| Analysis of pairwise interactions (microbe-microbe and host-microbe) of different types (competition, parasitism, etc.) with a join matrix of GEMs, and modelling of microbial communities given the relative abundances, used to personalize community biomass reaction and simulating under different diets. | No | Microbiome modelling toolbox | ||
| Predicting growth rates and metabolic fluxes from microbe abundances as input. Using an heuristic optimization approach based on L2 regularization to allow different growth rates per strain. | No | MICOM | ||
| Dynamic | ||||
| Exploring the metabolic variability among bacterial strains and identifying interactions, across different single-carbon-source conditions. They use a combination of a graph-theoretic approach together with a metabolic model. | No | |||
| Improving bioprocessing of cellulose with a clostridial consortia, with DMMM. | No | |||
| Designing of uranium bioremediation scenarios with two competing heterogeneous species | No | DMMM | ||
| Study of impact of lactate vs acetate addition on the composition of uranium-reducing community. In-vivo validation of | Yes | d-OptCom | ||
| Simulation of spatiotemporal dynamics of microbial communities, predicting species ratios and investigating the influence of spatial structure on competition in mutualistic systems, and with a competitor between the cross-feeding pair. | Yes | COMETS | ||
| Combining metabolic model with statistical analysis and calibration to experimental data, in this case related to Lenski’s experiment LTEE. | Yes | MCM | ||
| Visualization of metabolic interaction networks between microbes in a community. | No | VisANT | ||
| Analysis of evolution. LTEE: divergence in glucose-limited conditions, with daily transfers. | No | evoFBA | ||
| Analysis of interactions and spatial and temporal distributions of microbes in communities using individual-based metabolic modelling. | No | BacArena | ||
| Study of cross-feeding with short-chain fatty acids from glucose in the human gut microbiome, using DMMM with spatial addition. The | No | |||
| Study of the dynamics of nitrification-derived N oxide production, with aerobic ammonia- and nitrite-oxidizing bacteria, using DMMM. | Yes | |||
| Analysis of diauxic shift in two homogeneous subpopulations, combining ordinary differential equations (ODE) with GEMs. | No | Daphne | ||
| Simulation of heterogeneous microbial communities behaviour over time with ODE and GEMs under perturbations, i.e. changes in availability of metabolites and biomass of different strains. | No | MMODES | ||
Fig. 2Microbial community optimization/design goal categories. Section 5 describes each category in detail. Table 4 shows detailed applications and methods of these different categories. A. Optimize production of a metabolite of interest (red circle) depending on community parameters. B. Optimize distribution of the reactions within a metabolic pathway among different strains. C. Optimize individual strain growth to reach a stable community over time. D. Optimize concentration of nutrients (circles) available in the microbial community medium. E. Optimize physical distribution of the strains in the community. The flexible optimization category covers all the optimization goals. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Engineering modelling applications. Grouped by the optimization community goal. Focus on optimization/engineering topics. ‘Production’ group includes to optimize different community parameters (strains ratio, carbon source ratio, initial biomass, etc). GR = Growth Rate. Output means the configuration parameters that are predicted. If there is a software available, it is referred to and linked in the column ‘references’ too.
| Specific goal of optimization | Output | Strains | Results and additional details | Ref. |
|---|---|---|---|---|
| Production | ||||
| Maximizing ethanol production | carbon source ratio (glucose/xylose) mutant initial biomasses | ethanol productivity of ~ 1.08 gr/L/h | ||
| Maximizing flavonoids production | carbon sources ratio (glucose/glycerol) strains ratio | Using a scaled-Gaussian model: carbon source ratio of 0:1 (glucose:glycerol), strains ratio of 7:3 (upstream:downstream) Production of flavonoids to 40.7 ± 0.1 mg/L, i.e. a 970-fold improvement Also | ||
| 2 maximization goals: methane production (high community GR) methane yield (low community GR) | initial biomasses (strains ratio) flux rates (input and output metabolites) | Predicted (max. methane, ATP and biomass yield) and some Low biomass yield per strain, vs community goal 2 first strains consortium: 0.45 mol. methane/mol. ethanol | ||
| Maximizing yield | initial glucose concentration for stable consortia strains ratio uptake glucose and glycerol | acetate specialist CV101-‘fermenter’ glycerol specialist CV116 | 3 mutants after evolution in-vivo, with different GRs Glucose limited conditions (LTEE) Chemostat model of competition for a simple sugar >0.0033% of acetate specialist to allow a viable consortium Strain rations: CV101:CV103:CV116 ~= 0.10:0.65:0.025 CV103 best takes up the limiting resource glucose, but excretes acetate and glycerol (and/or a closely-related compound, glycerol 3-phosphate) | |
| Maximizing (together): community biomass yield per single strain (OptCom fixed goal) | strains ratio substrate uptakes | Strain ratio: 2:1 formate and hydrogen accumulation = 0 Additional | OptCom | |
| Maximizing (together): community biomass yield per single strain (OptCom fixed goal) | strains ratio O2/CO2 ratio | filamentous anoxygenic phototrophs (FAP) related to sulphate-reducing bacteria (SRB) | Fluxes ratio O2/CO2 reactions: 0.03–0.07 Strain ratio: 1:6:1 experimentally, and from 1:5:1 to 3:5:1 with metagenomics data SYN/FAP strain ratio: 1.5–3.5 | OptCom |
| Maximizing (together): community biomass yield per single strain (OptCom fixed goal) | strains ratio substrate uptakes | C. cellulolyticum D. vulgaris G. sulfurreducens | Biomasses: 0.8:0.1:0.13 acetate: 2.7 - CO2: 3.3 - Several metabolite fluxes details in Fig.5 | OptCom |
| Maximizing uranium reduction | strains ratio acetate and Fe(III) uptakes | Two first ones are uranium reducers | Carbon source: lactate = 5 mM In ammonium excess condition ([NH4] = 400 μM) Decrease in the biomass of the uranium-reducing species (SO, GS): Strain ratio max.community biomass: 0.056:0.051:0.055 Strain ratio max.uranium reduction: 0.039:0.041:0.056 Acetate (GS/RF): 14.9/1.49 when max.uranium reduction Fe(III) (SO/GS/RF): 28.3/110/2.06 when max.uranium reduction Alternative optimization objective in the manuscript | OptCom |
| 2 cases of study: maximizing butyrate production maximizing atrazine degradation | Interventions in medium composition or biomass of strains | Predict how to modify the community over time to reach a state of maximum performance Intervention for max. butyrate: inulin increase Intervention for max. atrazine degradation: depending on the microbiome state, increase of the biomass of | MDPbiomeGEM | |
| Pathway distribution | ||||
| Optimizing metabolite secretion | medium composition 2 selected strains secreted metabolite | 122 strains (6 from | secreted emergent metabolites (highlighting the most common ones), with their associated two-strain consortium and medium composition | |
| Maximizing growth or compound yield | Allocated reactions per strain | 2 generic bacteria with reduced central carbon metabolism | Given metabolic reactions to distribute Strains can only survive through cross-feeding | |
| Minimizing number of species | Selected species to combine in the community | Human gut microbiome | Graph-based approach (not GEM) combined with Integer Linear Programming (ILP) Given selected substrates and products, and a set of available species Identify putative metabolic pathways from substrates to product Glycolysis pathway, glucose → pyruvate, 284 species: minimal solution with one species was found. Also, they forced for multi-species solution With 10,000 random pairs of substrate-product metabolites, 1–3 species are selected among 2051 species | CoMiDA |
| 2 cases of study: maximizing antibiotics production, maximizing 1,3-propanediol and methane yield Secondary goal: production | All reactions to include and their distribution among strains | Results: Case study 1 (antibiotics): 4 solutions with 528 reactions (2 transports, 3 insertions, and 28 endogenous reactions) Case study 2 (industrial): 6 solutions with 110 reactions (1 transition and 10 endogenous reactions) | MultiPlus | |
| Optimizing metabolic exchange rates | carbon/nitrogen exchange and uptake rates kinetic parameters | Model parameters adjusted to Anaerobic species with hydrogen and nitrogen cross-feeding Co-cultures with uni- and multidirectional metabolic interactions The metabolic models can simulate their experimental data, in 4 different cultivation conditions (with/out NH4 and/or NO3), with distinct metabolic capabilities | ||
| Surviving under constraints | Cross-feeding partnerships and division of labor | Results: core: 91 combinations of 2 strains. Split the TCA cycle into two halves full with reduced functionalities: 2207 combinations for 2 strains, and 2402 for 3 strains. At least 215 and 203 internal reactions to grow, respectively for 2 and 3 strain consortia. Loss one reaction is not compensated with adding one metabolite in the medium (nonlinear boundary) | DOLMN | |
| Maximizing ethanol yield | KO in strains | Analysis of two-step fermentation pathway of 6,649,115 possible single KO analysed scenarios Ethanol yield increased at 170% of WT (for 867 KO candidate pairs) | BioLEGO 2 | |
| Stability | ||||
| Maximizing (together): biomass per single strain community biomass concentration (cells/L) | strains ratio | Auxotrophic | Biomass ratios (approx. values from | dOptCom |
| GR in auxotroph evolution | strains ratio | Glucose minimal medium, with uptake rate 10 mmol/gDW/hour Increased GR by 3 folds, while decreased growth in mono-culture Strain ratio depending on the aa uptake rate | ||
| Common growth | strains ratio cross-feeding rate spatial distribution | Strain ratios: Spatial distribution: presence of a strain competitor between cross-feeding species reduces the growth of those strains | COMETS | |
| GR with optimum distribution of resources | metabolites (amino-acids) consumption | Quantifying diet-induced metabolic changes of the human gut microbiome, using metabolomics data | CASINO | |
| Common growth | strains ratio community GR | 4 Gut microbiome (9 species) | 4 GR: 0.736 gDWh−1 Strains ratio: Ec1-Ec2 = 50%, Ec3-Ec4 = 50%. Direct competition Ec1-Ec4 and Ec2-Ec3 Gut microbiome case of study: values depending on fibre uptake from GR: ~0.06–0.08 gDWh−1, variable depending on fibre uptake | SteadyCom |
| Medium composition | ||||
| Minimizing the cost of metabolic cooperation | Combination of nutrients allowing synergistic growth | Selected nutrients: | ||
| Spatial organization | ||||
| Spatial Partitioning | -spatial distribution biofilm thickness growth with by-products | Results: Tendency of the two bacteria to spatially partition, as observed experimentally. Nutrient gradients influence (oxygen-top-aerobic, glucose-bottom-anaerobic) Different biofilm thickness than isolated | ||
| Spatial Partitioning | -spatial distribution strain ratio shift due to perturbations | 2 case of study (reduced models): | Study of soil habitat Compared to COMETS and experimental data | IndiMeSH |
| Flexible | ||||
| Optimizing PHA accumulated | initial biomasses NH4 concentration sucrose secretion rate | biomasses: 2, 0.2 gr/L NH4: 0.5 mM sucrose secretion rate: 40% PHA production: 22.43 mM/100 h | FLYCOP | |
| Stability maximization (common growth) | strains ratio amino acid secretion rate | 4 | strains ratio: Ec1 = 35%, Ec2 = 10%, Ec3 = 15%, Ec4 = 40% aa secretion rate (in terms of %GR): Arg = 1.5, Lys = 2, Met = 1.6, Phe = 1 | FLYCOP |
| Several optimization goals: maximizing yield or biomass or GR, and minimizing time | Uptake rates per strain (glucose, acetate, oxygen) | 2 glucose specialist acetate specialist | Different configurations are predicted depending on the optimization goal. A polymorphism with 2 strains growing is the best configuration under limited oxygen conditions; else only one strain growing | FLYCOP |